Search clinical trials for: Subject number

Total 21456 results

Temple University

Completed

Rabeprazole Protection of Aspirin Induced Gastric Damage.

Normal Subjects

United States
Anthera Pharmaceuticals

Completed

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease (PLASMA 2)

Coronary Artery Disease

United States
Genentech, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma

Allergic Asthma
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan

Rheumatoid Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee

Osteoarthritis

Poland, Spain, Hong Kong, United States, Canada, Hungary, Netherlands, Brazil, Mexico, Argentina
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Effect of Lecozotan SR on the QTc Interval

Healthy | Alzheimer Disease

France
Amgen

Completed

Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects

Anemia
Amgen

Completed

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Nephrology
Novartis

Completed

Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Amgen

Completed

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy

Anemia
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating PPM-204 In Subjects With Type 2 Diabetes

Diabetes Mellitus

China, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
Braintree Laboratories

Completed

BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Colonoscopy

United States
Sheba Medical Center

Completed

Characteristics of Post-Traumatic Stress Disorder (PTSD) and Non-PTSD Subjects

PTSD
Braintree Laboratories

Completed

BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Colonoscopy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects

Healthy

United States
Ramsey, Bonnie, MD
Cystic Fibrosis Foundation; CF Therapeutics Development Network Coordinating... and other collaborators

Completed

Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis (SEER)

Cystic Fibrosis

United States
Amgen

Completed

Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Cierra

Suspended

PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)

Patent Foramen Ovale

France, Germany, Belgium
Cierra

Completed

The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness

Foramen Ovale, Patent

Germany
Astellas Pharma Inc
Astellas Pharma US, Inc.; Advanz Pharma

Completed

Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery

Atrial Fibrillation | Atrial Flutter

Poland, United States, Canada, Argentina, Denmark, India
Cierra

Suspended

PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness (Paradigm IV)

Stroke | Migraine | Transient Ischemic Attack | Decompression Illness | PFO

Germany
AstraZeneca

Completed

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

Pediatric Hypertension

United States, Hungary, Slovakia, Belgium
AstraZeneca

Completed

A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma

Colorectal Cancer

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

China
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis

Ankylosing Spondylitis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects

Healthy

United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects

Alzheimer Disease

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects

Alzheimer Disease
Pfizer

Terminated

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

Dyslipidemia | Hyperlipidemia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors

Neoplasms

Japan
Northeastern Ohio Universities College of Medicine
Mercy Medical Center; Aultman Health Foundation; Akron General Medical Center; Forum... and other collaborators

Suspended

Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome

Diabetes Mellitus, Type 2 | Metabolic Syndrome X

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

Schizophrenia

United States
Pfizer

Completed

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease (ILLUSTRATE)

Coronary Disease | Coronary Arteriosclerosis | Hyperlipidemia

United States, Spain, Canada, Poland, Belgium, Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

Depression

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects

Healthy

China
Wyeth is now a wholly owned subsidiary of Pfizer
Amgen

Completed

Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis

Psoriasis

Belgium, France, Spain, Germany, Italy, Austria, Poland, Romania, Netherlands, Hungary
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating SKI-606 Administered to Healthy Subjects

Healthy

Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating IMA-638 in Healthy Japanese

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Alzheimer Disease

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating IMA-638 in Asthma

Asthma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects

Schizophrenia

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Single Ascending Dose Study of SRA-444 in Healthy Subjects

Alzheimer Disease

Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Vaccine in Adults With HIV

HIV Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects

Diabetes Mellitus

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy

Osteoarthritis | Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

Schizophrenia

United States
Abbott

Completed

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States

Search clinical trials for: Subject number

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations